- Home
- BTMD vs OFS Comparison
BTMD vs OFS Comparison
Compare BTMD & OFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTMD
- OFS
- Stock Information
- Founded
- BTMD 2012
- OFS 2001
- Country
- BTMD United States
- OFS United States
- Employees
- BTMD N/A
- OFS N/A
- Industry
- BTMD Medicinal Chemicals and Botanical Products
- OFS Finance/Investors Services
- Sector
- BTMD Health Care
- OFS Finance
- Exchange
- BTMD Nasdaq
- OFS Nasdaq
- Market Cap
- BTMD 127.8M
- OFS 120.2M
- IPO Year
- BTMD N/A
- OFS 2012
- Fundamental
- Price
- BTMD $3.04
- OFS $8.38
- Analyst Decision
- BTMD Buy
- OFS
- Analyst Count
- BTMD 2
- OFS 0
- Target Price
- BTMD $6.00
- OFS N/A
- AVG Volume (30 Days)
- BTMD 127.2K
- OFS 39.7K
- Earning Date
- BTMD 08-06-2025
- OFS 07-31-2025
- Dividend Yield
- BTMD N/A
- OFS 16.45%
- EPS Growth
- BTMD 1489.51
- OFS N/A
- EPS
- BTMD 0.88
- OFS 0.76
- Revenue
- BTMD $199,073,000.00
- OFS $43,337,000.00
- Revenue This Year
- BTMD $5.87
- OFS N/A
- Revenue Next Year
- BTMD $8.59
- OFS N/A
- P/E Ratio
- BTMD $3.32
- OFS $10.82
- Revenue Growth
- BTMD 6.32
- OFS N/A
- 52 Week Low
- BTMD $2.87
- OFS $7.75
- 52 Week High
- BTMD $7.25
- OFS $9.80
- Technical
- Relative Strength Index (RSI)
- BTMD 28.39
- OFS 42.55
- Support Level
- BTMD $3.88
- OFS $8.18
- Resistance Level
- BTMD $4.20
- OFS $8.40
- Average True Range (ATR)
- BTMD 0.25
- OFS 0.16
- MACD
- BTMD -0.15
- OFS -0.01
- Stochastic Oscillator
- BTMD 0.57
- OFS 21.48
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.
About OFS OFS Capital Corporation
OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its business objective is to generate current income and capital appreciation by investing in middle-market companies in the United States. The company focuses on investments in senior secured loans, including first lien, second lien, and unitranche loans, as well as subordinated loans and, to a lesser extent, warrants, and other equity securities.